GlassScriptPhysician profile
Satish Kulkarni
NPI 1295724995
$11,150.20
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,246 · 2020: $1,329 · 2021: $4,196 · 2022: $1,218 · 2023: $1,143 · 2024: $17.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Validus Pharmaceuticals LLC | $2,885.81 | 2019-2023 | Equetro |
| Alkermes, INC. | $1,454.27 | 2019-2023 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $1,163.30 | 2019-2023 | Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $983.40 | 2020-2023 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $874.71 | 2019-2024 | Rexulti, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $800.41 | 2019-2023 | Austedo Xr, Uzedy |
| Neurocrine Biosciences, INC. | $697.25 | 2019-2023 | Ingrezza |
| Vanda Pharmaceuticals INC. | $525.43 | 2019-2022 | |
| Lundbeck LLC | $371.52 | 2019-2023 | Rexulti |
| Allergan, INC. | $354.99 | 2019-2020 | |
| Abbvie INC. | $347.94 | 2021-2023 | |
| Indivior INC. | $200.79 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $181.47 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.15 | 2019-2023 | Trintellix |
| Neuronetics, INC. | $73.32 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $58.25 | 2019 | |
| Axsome Therapeutics, INC. | $38.67 | 2022-2023 | Sunosi |
| Janssen Biotech, INC. | $14.46 | 2022 | |
| Ironshore Pharmaceuticals INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satish Kulkarni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.